Management of dermatologic toxicities related to epidermal growth factor receptor inhibitor therapy across Europe: can we get a consensus?

To date, there are no phase III trial data that can guide healthcare professionals in managing toxicities of epidermal growth factor receptor inhibitors (EGFRIs). This exploratory survey assessed the similarities and differences in nursing management of EGFRI-related toxicities across 10 European co...

Descripción completa

Detalles Bibliográficos
Autor principal: Lemmens, L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2011
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223953/
https://www.ncbi.nlm.nih.gov/pubmed/22276062
http://dx.doi.org/10.3332/ecancer.2011.220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223953/
https://www.ncbi.nlm.nih.gov/pubmed/22276062
http://dx.doi.org/10.3332/ecancer.2011.220

Ejemplares similares